SRSandra Rezar-Dreindl

Sandra Rezar-Dreindl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sandra Rezar-Dreindl has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Characteristics and Management of a Cohort of Patients with Asymmetric Thyroid Eye Disease and Unilateral Dysthyroid Optic Neuropathy Undergoing Unilateral Orbital Decompression Surgery

    by Sandra Rezar-Dreindl, Lorenz Wassermann, Johannes Engelmann, Thomas Neumayer, Stefan Sacu, Eva Stifter

    Background/Objectives: The aim was to describe the clinical characteristics and report the long-term outcomes of a cohort of patients with asymmetric thyroid eye disease (TED), including a subgroup with unilateral dysthyroid optic neuropathy (DON), treated with unilateral orbital decompression surgery alone or in combination with intravenous (IV) methylprednisolone. Methods: This retrospective study included 48 patients with asymmetric TED who all underwent orbital decompression with or without IV corticosteroid therapy between 2006 and 2020 at the Department of Ophthalmology and Optometry and Oral and Maxillofacial Surgery of the Medical University of Vienna, Austria. Results: The mean follow-up was 4.6 ± 2.6 years. Overall, 52% of the patients initially received IV corticosteroids followed by orbital decompression, and 73% underwent three-wall decompression. Mean visual acuity (VA) was 0.1 ± 0.5 logMAR at baseline and 0.1 ± 0.5 logMAR at final follow-up (p = 0.4). The mean reduction in proptosis was 4 ± 3 mm. Unilateral DON was diagnosed in 50% of the patients. In this subgroup, 67% were initially treated with IV corticosteroids and 79% underwent three-wall decompression. Mean reduction in proptosis was 5 mm. The final VA of the affected eye was <0.3 logMAR in 88% (21/24) of the patients with unilateral DON. Conclusions: Patients with asymmetric TED were predominantly treated with IV corticosteroids and received three-wall orbital decompression. Visual function could be maintained in a high number of cases with asymmetric TED and patients with unilateral DON.

  • Open Access

    Evolving Strategies in Pediatric Cataract Surgery: A 7-Year Analysis of Ocular Biometry and IOL Localization

    by Luca Schwarzenbacher, Belma Strugalioska, Gregor S. Reiter, Lorenz Wassermann, Sandra Rezar-Dreindl, Stefan Sacu, Eva Stifter

    Objectives: To evaluate temporal trends in ocular biometrics, patient demographics and surgical strategies for intraocular lens (IOL) localization in pediatric cataracts. Methods: This retrospective study included 291 eyes of 148 pediatric patients operated at a tertiary referral center between 2019 and 2025, comprising 219 operated eyes and 72 unaffected fellow eyes serving as intra-individual controls. Eyes were stratified into three chronological cohorts (2019–2020, 2021–2022, 2023–2025). Axial length (AL), white-to-white (WTW) diameter and central corneal thickness were analyzed in relation to the anatomical IOL placement. A generalized linear mixed model with a random intercept per patient accounted for the within-patient correlation between fellow eyes. Results: Mean AL increased from 18.91 ± 2.83 mm to 20.32 ± 3.19 mm (p = 0.004), whereas the increase in WTW diameter was not significant (p = 0.450). The age at surgery increased significantly across the periods (median 1.08, 1.33 and 3.13 years; p < 0.001), a general temporal effect that was not modified by the site of implantation (p = 0.32). Underlying etiology strongly influenced the approach: all eyes with Marfan syndrome received an iris-fixated IOL, whereas 90% of uveitic eyes remained aphakic. Femtosecond laser-assisted cataract surgery (FLACS) was used in 13 eyes and confined to the most recent period. Conclusions: Pediatric cataract surgery shows a progressive increase in the age at surgery that is not specific to any IOL localization, while the surgical approach is frequently determined by the underlying etiology. The increasing use of FLACS represents an institutional trend; the small number of cases and absence of outcome data preclude conclusions regarding its safety or feasibility.


  • Open Access

    Outcomes of Strabismus Surgery in Patients with Cranial Nerve Palsy

    by Laetitia Hinterhuber, Sandra Rezar-Dreindl, Ursula Schmidt-Erfurth, Eva Stifter

    Strabismus, or squint or deviating eyes, is defined as misalignment of the eyes when fixating on an object and is a common problem in ophthalmology. Palsy of the third, fourth or sixth cranial nerve is one of the leading underlying causes for paralytic strabismus, often requiring surgery. However, uncertainty regarding factors influencing surgical success remains. Background/Objectives: The purpose of this study is to review the outcome and influencing factors of strabismus surgery in patients with cranial nerve palsy. Methods: A retrospective study of 57 patients with third cranial nerve (CN3) palsy, fourth cranial nerve (CN4) palsy, sixth cranial nerve (CN6) palsy or combined nerve palsy who underwent strabismus surgery between October 2009 and December 2023 was conducted. Analyzed data included demographic details, type of surgical intervention, etiology of nerve palsy, pre- and postoperative angle of deviation (AOD), vertical deviation (VD), best-corrected visual acuity (BCVA), and refractive error. Results: Mean age was 41.29 ± 23.14 years with a mean follow-up of 10.8 ± 15.38 months. 30 patients (52.63%) had CN6 palsy, 12 patients (21.05%) had CN3 palsy, eight patients (14.04%) had CN4 palsy and seven patients (12.28%) had combined nerve palsy. Brain neoplasm was the most common cause of nerve palsy (33.33%). Mean preoperative AOD improved from 17.54° ± 10.68 to 7.13° ± 8.93 and from 17.21° ± 9.58 to 7.49° ± 9.75 for near and distance, respectively (p < 0.001). Changes in VD, refractive error, and BCVA were not statistically significant. Conclusions: Age, gender, preoperative AOD, subtype and etiology of nerve palsy had no significant influence on surgical outcomes, which are satisfactory in patients with cranial nerve palsy (80.7%).


  • Open Access

    Pediatric and Juvenile Strabismus Surgery Under General Anesthesia: Functional Outcomes and Safety

    by Jakob Briem, Sandra Rezar-Dreindl, Lorenz Wassermann, Katharina Eibenberger, Franz Pusch, Ursula Schmidt-Erfurth, Eva Stifter

    Background/Objectives: The aim of this paper was to evaluate the safety of surgical intervention using anesthesia and ophthalmological parameters in pediatric strabismus patients. The design involved retrospective case series. Methods: The setting was the Department of Ophthalmology, Medical University Vienna, Austria. Participants: In total, 208 children aged 0–18 years who underwent strabismus surgery due to exotropia or esotropia between 2013 and 2020 were included. Main outcomes and measures: Information regarding the duration of surgery, intra- and postoperative complications, the postoperative angle of deviation (AoD), and functional outcomes (visual acuity, stereovision) were analyzed. Results: The mean age at the time of surgery was 6.0 ± 4.1 years (range 0.6–18.0). The mean anesthesia time among all patients was 75.9 ± 19.3 min. The mean surgery and anesthesia time did not differ between the age groups. Longer anesthesia durations and surgery durations did not have a significant effect on the occurrence of intraoperation complications (p = 0.610 and p = 0.190, respectively). Intraoperative complications were recorded in 53% (most frequent triggering of oculocardiac reflex (OCR)) of the patients, and postoperative complications in 22% (the most frequent were postoperative nausea and vomiting and pain). An OCR was triggered more often in children older than 6 years than in younger children (p = 0.016). The mean angle of deviation was significantly reduced from preoperative to postoperative measurements. Preoperative stereovision tests were positive in 35% of the patients and increased to over 80% postoperatively. Conclusions: Strabismus surgery performed under general anesthesia in children aged 0 to 18 years is safe with regard to both surgical and anesthetic complications. A significant decrease in the angle of deviation and high rate of stereovision could be achieved with a low rate of re-treatments. However, the retrospective design, absence of standardized documentation, and limited sample size may affect the consistency and comparability of this study’s findings.


  • Open Access

    Retinopathy of Prematurity: Incidence, Risk Factors, and Treatment Outcomes in a Tertiary Care Center

    by Mara Nike Blazon, Sandra Rezar-Dreindl, Lorenz Wassermann, Thomas Neumayer, Angelika Berger, Eva Stifter

    Retinopathy of prematurity (ROP) remains a major cause of childhood blindness. Its pooled prevalence worldwide is 31.9%, and that of severe ROP is 7.5% among prematurely born babies. Investigating risk factors is essential for improving early detection and treatment outcomes. Purpose: To determine the frequency and stages of ROP cases and evaluate the treatment methods for premature infants at the Medical University of Vienna. Methods: In this retrospective study, 352 children who underwent ROP screening between 2018 and 2021 with a gestational age (GA) ≤ 32 weeks and/or a birth weight (BW) ≤ 1500 g were included. Results: ROP was found in 144 (40.9%) of the 352 screened premature infants, with 17 (4.8%) requiring treatment. Significant risk factors included GA and BW, while sex and pregnancy type were not significant. The mean GA was 27.7 ± 2.5 weeks, and the mean BW was 989.1 ± 359.7 g. Infants with ROP had a lower GA (25.9 ± 1.7 weeks) and BW (778.6 ± 262.4 g) than those without ROP (28.9 ± 2.2 weeks; 1134.9 ± 345.9 g). GA and BW were significantly lower in infants developing ROP (p < 0.001). Stage 2 ROP was the most common severity in 74 children (51.4%). Laser therapy was the most common first-line treatment, used in 11 infants (64.7%), followed by anti-VEGF therapy, used in 6 infants (35.3%). Children were treated within 1.0 ± 0.6 days on average. Of the 17 infants treated, 14 (82.4%) showed initial regression. Three infants (17.6%) required re-treatment: two with initial anti-VEGF therapy and one after laser therapy. Conclusions: The findings provide insights into ROP’s prevalence and treatment preferences at a university tertiary care center. GA and BW were confirmed to be significant predictors, aiding in early detection and informing treatment decisions. These insights will enable comparisons with similar studies and contribute to improved patient care.


  • Open Access

    An Analysis of Ocular Biometrics: A Comprehensive Retrospective Study in a Large Cohort of Pediatric Cataract Patients

    by Luca Schwarzenbacher, Lorenz Wassermann, Sandra Rezar-Dreindl, Gregor S. Reiter, Ursula Schmidt-Erfurth, Eva Stifter

    Objectives: This study aims to provide a comprehensive analysis of ocular biometric parameters in pediatric patients with cataracts to optimize surgical outcomes. By evaluating various biometric data, we seek to enhance the decision-making process for intraocular lens (IOL) placement, particularly with advanced technologies like femtosecond lasers. Methods: This retrospective comparative study included pediatric patients with cataracts who underwent ocular biometric measurements and cataract extraction with anterior vitrectomy at the Medical University of Vienna between January 2019 and December 2021. Parameters measured included corneal diameter (CD), axial length (AL), corneal thickness (CT) and flat and steep keratometry (Kf and Ks). The study explored the correlations between these parameters and IOL placement. Results: A total of 136 eyes from 68 pediatric patients were included in the study. Significant positive correlations were found between corneal diameter, age and AL. The mean CD was 11.4 mm, mean AL was 19.5 mm, CT was 581.2 ± 51.8 µm, Kf was 7.76 ± 0.55 mm and Ks 7.41 ± 0.59 mm, respectively. Older pediatric patients with larger corneal diameters and longer ALs were more likely to receive in-the-bag IOL implantation. Conversely, younger patients often required alternative IOL placements or remained aphakic. Our data indicated that over 95% of the study population and all patients aged one year and older had a corneal diameter of 10 mm or larger. Conclusions: Detailed ocular biometric analysis is crucial for optimizing both surgical outcomes and postoperative care in pediatric cataract patients. The positive correlations between CD, age and AL underline the importance of individualized surgical planning tailored to each patient’s unique anatomical features. Additionally, our findings suggest that the use of a femtosecond laser is both feasible and safe for pediatric patients aged one year and older, potentially offering enhanced surgical precision and improved outcomes.


  • Open Access

    Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves’ ophthalmopathy – a 1-year follow-up: study protocol for a randomized controlled trial

    by Lindsay Brammen, Philipp Riss, Julius Lukas, Alois Gessl, Daniela Dunkler, Shuren Li, Asha Leisser, Sandra Rezar-Dreindl, Katharina Eibenberger, Andreas Selberherr, et al.

    Graves’ disease (GD) is characterized by thyrotoxicosis and goiter and arises through circulating autoantibodies that bind to, and stimulate, the thyroid hormone receptor (TSHR). A temporal relation between the onset of hyperthyroidism and the onset of ophthalmopathy, a common extrathyroidal manifestation, has been demonstrated. Graves’ ophthalmopathy (GO) is typically characterized by an inflammation and expansion of the extraocular muscles and an increase in retroorbital fat. There are currently three forms of therapies offered for hyperthyroidism caused by Graves’ disease: antithyroid drugs (ATD) (thionamides), radioiodine ablation (RAI) and thyroidectomy (Tx). To date, there is no clear recommendation on the treatment of Graves’ disease and GO, mainly due to the individuality of the disease in each patient. The aim of the study is to examine the difference in the outcome of GO in patients with moderate-to-severe GO who receive Tx versus further ATD after suffering their first relapse of GO, or in which GO stays the same following the initial decrease in ATD therapy after 6 months. This prospective randomized clinical trial with observer-blinded analysis will analyze 60 patients with moderate-to-severe GO who receive Tx versus ATD without surgery. Main outcome variables include: muscle index measurements via ultrasound and thyroid antibody levels. Additional outcome variables include: Clinical Activity Score (CAScore), NOSPECS score, superonasal index measurements via ultrasound, and quality of life score. This study should allow for better therapeutic choices in patients with moderate-to-severe GO. In addition, it should demonstrate whether the outcome of GO in patients with moderate-to-severe GO is better in those who receive early Tx versus further ATD. Furthermore, this study will aim to establish a standard glucocorticoid scheme before and after Tx in patients with moderate-to-severe EO. Eudra-CT: 2015–003515-38; Medical University of Vienna Protocol Record 1839/2015. Date of Ethics Committee approval: 19 January 2017. Registered on 27 January 2017.